Iclusig 15 MG
Ended Awarded
- Contract number
- 36C24526N0161
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI ENNFDLWFC6L1
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $42,592
Award facts
- Contract value 100% obligated
- $42,592.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Earth City, MO 63045, USA
Award details come from SAM.gov/FPDS.
About this award
Takeda Pharmaceuticals America, Inc. was awarded a delivery order by Veterans Integrated Service Network 5 (VISN 5) on November 21, 2025, for ICLUSIG 15 mg pharmaceutical product with a ceiling value of $42,592.17. This firm fixed-price delivery order, which is not designated as a small business set-aside, will be performed in Earth City, Missouri and is scheduled for completion by November 26, 2025. The award was issued under Takeda's General Services Administration (GSA) Schedule for Pharmaceuticals and Drugs, enabling streamlined procurement of this specialized oncology medication to support VA healthcare operations.
This delivery order represents a continuation of Takeda's established role as a critical supplier of ICLUSIG to the Department of Veterans Affairs through multiple VISNs. The award is placed against a larger Blanket Purchase Agreement valued at $123.5 million that specifically provides ICLUSIG to VA medical facilities through the National Acquisition Center, as well as Takeda's GSA Federal Supply Schedule contract valued at approximately $2.9 billion covering pharmaceutical and hematology-related products. As a large, foreign-owned subsidiary of Takeda Pharmaceutical Company Limited, the company has consistently supplied various dosages of ICLUSIG (ranging from 10 mg to 45 mg tablets) to support cancer treatment programs across the VA healthcare system.
Quick answers
Who was awarded contract 36C24526N0161?
36C24526N0161 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on November 21, 2025.
How much is contract 36C24526N0161 worth?
The government has obligated $42,592 on 36C24526N0161.
Is contract 36C24526N0161 an order under another contract?
Yes. 36C24526N0161 is a delivery order under 36F79725D0180, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0161 competed?
The extent of competition for 36C24526N0161 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award